← Back to all trials
Recruiting
NCT05624073
Blind Tracheal Intubation Through Supraglottic Airway Devices
Conditions: Respiration and the Airways With Laryngeal Masks
Sex: All
Ages: 18 Years – 55 Years
Healthy volunteers: 1
Enrollment: 70
Sponsor: Cairo University
Location: Egypt
Summary
Tracheal intubation is considered the gold standard for protecting the airway.
As the supraglottic airway devices (SADs) could be inserted without laryngoscopy, so that SADs with different designs and safety issues could be used to manage difficult airways in anesthesia and emergency medicine with continuous patient oxygenation &ventilation, less hemodynamic stress response and less postoperative complications.
These advantages encourage the use of a proper SAD as a conduit for endotracheal intubation in stressful conditions.
This study will be carried out to compare the Air-QTM Blocker and LarysealTM Pro for blind tracheal intubation during elective ophthalmic surgeries under general anesthesia.
Intubation through SAD can be performed using a fiber-optic bronchoscope or blindly.
Blind intubation is meaning that the tube is inserted through SAD without direct visualization of the airway.
Success rate of blind intubation ranges between 15% and 97%, mostly depending on the type of used SAD, patient characteristics and operator skills.
The availability of blind intubation through SAD is important in cases of difficult intubation (either anticipated or unanticipated) especially if fiber-optic is not available, so that SAD will be convenient for untrained personnel.
Eligibility Criteria
Inclusion Criteria:Age: 18-55 years old.ASA I&II.Both sexes.El-Ganzouri Airway Score < or =2Exclusion Criteria:History of upper respiratory tract infections.History of obstructive sleep apnea (OSA) or STOP Bang-Score > 4.Potentially full stomach (trauma, morbid obesity BMI> 35 Kg/m2, pregnancy, history of gastric regurgitation and heart burn).Esophageal reflux (hiatus hernia).Coagulation disorders.
Source: ClinicalTrials.gov (NCT05624073). StuddyBuddy aggregates publicly available trial information.